Login to Your Account

Financings Roundup

Elevation Pharma 'Golden' With $30M for COPD Therapy

By Marie Powers
Staff Writer

Thursday, January 5, 2012
Elevation Pharmaceuticals Inc. closed a $30 million Series B financing, led by new investor Novo Ventures, to advance its aerosol therapy for chronic obstructive pulmonary disease (COPD).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription